Needle-free drug delivery devices are novel techniques to introduce drugs into patient’s body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. Needle-Free Drug Delivery market report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications.
Needle-free drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The market for these technologies has been extensively analyzed on the basis of factors such as technology, durability, value, user preference, regulatory norms and others. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
Browse the Needle-Free Drug Delivery Devices Market Research Report with complete TOC athttp://www.transparencymarketresearch.com/needle-free-delivery-devices-market.html
Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these applications has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for the development of home-care and self medication devices and others. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
Get Free Sample Report athttp://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=447
Geographically, the needle-free drug delivery devices market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market for these geographies has been extensively analyzed on the basis of factors such as regulatory environment, usage pattern, product penetration and others. The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the needle-free drug delivery devices market report comprises a qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis.
Browse More Medical Devices Related Research Reports athttp://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
The needle-free drug delivery devices market report also provides a highlight of the competitive landscape of the market, wherein the market share analysis of the leading players in the needle-free drug delivery devices market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the needle-free drug delivery devices market such as Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, 3M, Pharmajet, and Zogenix, Inc. Market players are profiled on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
No comments:
Post a Comment